Education
About Us
Working with TipRanks
Follow Us
Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Earnings Data
Report Date
Feb 16, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-2.57Last Year’s EPS
-10.4Same Quarter Last Year
Based on 2 Analysts Ratings
Earnings Call Summary
Q2 2026
Earnings Call Date:Nov 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in clinical trials and substantial reduction in operating expenses, indicating effective cost management. Nonetheless, challenges in patient recruitment for the oncology trial and concerns about cash reserves present potential hurdles. The company's strategic focus on its core projects while managing resources optimally reflects a balanced approach.Company Guidance
Australian Oncology Trial Progress
The ongoing progress in the Australian oncology trial of the Hemopurifier shows promising results. All three participants in Cohort 1 completed a single 4-hour Hemopurifier treatment without any device deficiencies or immediate complications. The trial is advancing to the second cohort with plans for participants to receive two Hemopurifier treatments during a 1-week treatment period.
Financial Expense Reduction
Operating expenses for the quarter ending September 30, 2025, were approximately $1.5 million, down by approximately 48% from $2.9 million in the same period of 2024. This reduction was reflected across payroll, general and administrative expenses, and professional fees.
Preclinical R&D Developments
Aethlon Medical presented preclinical data on Long COVID at the Keystone Symposium, demonstrating the binding of extracellular vesicles from Long COVID patients to the Hemopurifier. The company is preparing a manuscript with UCSF Medical Center collaborators for publication.
AEMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AEMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $4.20 | ― | ― |
Aug 13, 2025 | $12.30 | $11.70 | -4.88% |
Jun 26, 2025 | $19.40 | $12.50 | -35.57% |
Feb 12, 2025 | $53.44 | $50.50 | -5.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Aethlon Medical Inc (AEMD) report earnings?
Aethlon Medical Inc (AEMD) is schdueled to report earning on Feb 16, 2026, After Close (Confirmed).
What is Aethlon Medical Inc (AEMD) earnings time?
Aethlon Medical Inc (AEMD) earnings time is at Feb 16, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AEMD EPS forecast?
AEMD EPS forecast for the fiscal quarter 2026 (Q3) is -2.57.